NCPA Media: Health Care

  • Oct 09, 2015

    Are laws, regs pricing consumers out of generic drugs?

    Managed Healthcare Executive: “Slow drug approvals by FDA are unnecessarily holding back competition that could alleviate some of the price hikes on generic drugs,” says NCPA Senior Fellow Devon Herrick in a Managed Healthcare Executive story.

  • Oct 02, 2015

    Obamacare Mistakes: Consumers Continue to Make Errors in Choosing Benefits

    The Street: “Consumers are making critical mistakes when shopping for healthcare coverage because they’re only looking at the monthly payments, and aren’t taking the time to compare other information. This is made especially difficult by unfriendly and cluttered provider web sites,” says NCPA Senior Fellow Devon Herrick in an article at The Street.

  • Oct 01, 2015

    GAO: $30B Incentive Program Making It More Difficult to Share Electronic Health Records

    CNS News: Since the Electronic Health Records Incentive Programs are having so many implementation issues, NCPA Contributing Fellow Lawrence Pivnik suggests alternative, more easily implementable, and more private alternatives for storing patient information, in a CNS News story.

  • Oct 01, 2015

    NCPA: Mergers, market manipulation fuel rise in generic-drug prices

    American Pharmacy News: “Wholesale generic drugs are facing less market competition, which is driving up their prices,” says NCPA Senior Fellow Devon Herrick in an American Pharmacy News story.

  • Sep 29, 2015

    Detroit's new cancer facility aims to spark economic growth

    Modern Healthcare: “States are increasingly approving multiple healthcare facilities in one vicinity to promote market competition,” says NCPA Senior Fellow Devon Herrick in a Modern Healthcare story.

  • Sep 24, 2015

    Should Government Control The Price Of Prescription Drugs?

    International Business Times: “Shrinking the FDA to reduce the amount of money pharmaceutical companies must spend to create new medicines isthe smartest approach to lowering drug costs,” says NCPA Senior Fellow John R. Graham in an International Business Times story.

  • Sep 22, 2015

    Legal Drug Dealers Commit Highway Robbery

    Town Hall: “Manufacturers are raising prices on old remedies because there is little competition in treating rare diseases in the United States,” says NCPA Senior Fellow Devon Herrick in a Town Hall commentary.

  • Sep 21, 2015

    Could Supply Issues Price Consumers Out of Generic Drugs? NCPA Senior Fellow Devon Herrick cites market consolidation, product dumping, and raw material shortages as reasons for growing generic drug costs, according to a article.

porno izle